There have been numerous headlines about stem cells on the news and different platforms, as activist investor Jason Hope explains. Though there is much controversy about stem cells, as some organizations and groups protest their use due to ethical reasons, many people consider stem cells an innovative resource that could be used to treat diseases.
Research scientists aim to normalize the usage of stem cells in science. Due to promising results, biotech startups and independent companies are incorporating stem cells into their research within the rejuvenation field. According to Jason Hope, though the extraction of embryonic stem cells and stem cell lab growth twenty years ago sparked much excitement in the medical community over possible new cures for:
Heart disease, Alzheimer’s, and Parkinson’s disease, no significant strides have been made in that direction, Jason Hope shares. Currently, stem cells are used to grow blood cells to treat patients suffering from blood disorders. The limited use of stem cells results from a lack of research and resistance from some in the scientific community.
Philanthropist and entrepreneur Jason Hope believes that more research is required to fully understand the benefits of stem cell use, including the use of stem cells in possible applications in medicine. The philanthropist and activist investor has contributed to the medical community through the SENS Organization and knows that unless scientific research is done, the use of stem cells will continue to be experimental.
Long-term research needs to occur for the safe use of stem cells to treat medical conditions and in the field of anti-aging and age-related diseases. Jason Hope comments how the SENS Organization(Strategies for Engineered Negligible Senescence) continues to forge ahead in researching how to prevent diseases from occurring.
Much of SENS research is focused on using stem cells for macular degeneration and preventing the rejection of stem cell organs. Currently, SENS is holding clinical trials in the treatment of Parkinson’s Disease. Though the clinical trials are slow, activist investor Jason Hope finally states on this concern, they give hope to people about the use of stem cells.